Guerbet Group

Guerbet is a healthcare company focused on medical imaging, with a history spanning 90 years. As a pioneer in contrast media, it is the only pharmaceutical group dedicated exclusively to this field. Guerbet operates in nearly 80 countries through a network of subsidiaries and distributors, providing a wide array of products for various imaging modalities, including CT scans, magnetic resonance imaging (MRI), ultrasound, and nuclear medicine. The company’s portfolio includes well-known brands such as Xenetix, Optiray, Dotarem, and Telebrix, among others. Additionally, Guerbet offers injectors and related medical devices aimed at enhancing patient diagnosis, prognosis, and overall quality of life.

Jean-François Blanc

Senior Vice President and Head of Interventional Business Unit

3 past transactions

Accurate Medical Therapeutics

Acquisition in 2018
Accurate Medical Therapeutics is develops embolization microcatheter for the interventional radiology and interventional oncology markets.

Mallinckrodt - CMDS business

Acquisition in 2015
Mallinckrodt - CMDS business contrast media and delivery systems

Medex Biomedical

Acquisition in 2004
Medex is specialized in injection systems and medical devices. The company offers injectors for CT and angiography examinations. It also has a large and comprehensive offering of disposables for CT and angiography examinations in addition to a selected range for MRI.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.